Extension of protocol HMR1726D/2001, a phase II study of the safety and efficacy of Teriflunomide (HMR1726) in multiple sclerosis with relapses

Chercheur principal: 

Jean-Pierre Bouchard

Organisme subventionnaire: 

Sanofi-Aventis (Canada)

Statut: 
Projet terminé

CIUSSS-CN Université Laval Alliance santé Québec